ImmunoGen, Inc.
IMGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$222,929 | -$222,929 | -$44,372 | -$104,133 |
| Dep. & Amort. | $1,783 | $1,783 | $2,101 | $4,028 |
| Deferred Tax | $0 | $0 | -$691 | $2,383 |
| Stock-Based Comp. | $25,615 | $25,615 | $14,321 | $14,167 |
| Change in WC | -$25,600 | -$25,600 | -$4,557 | $25,724 |
| Other Non-Cash | -$8,671 | -$8,671 | -$45,422 | -$30,536 |
| Operating Cash Flow | -$229,802 | -$229,802 | -$78,620 | -$88,367 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,364 | -$1,364 | -$917 | -$2,845 |
| Net Acquisitions | $0 | $0 | $1,426 | $2,312 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,364 | -$1,364 | $509 | -$533 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $25,649 | $356,844 | $0 | $2,873 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $27,554 | $355,744 | $195,742 | $2,873 |
| Financing Cash Flow | $27,554 | $355,744 | $195,742 | $2,873 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$203,612 | -$203,612 | $117,631 | -$86,027 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $478,750 | $478,750 | $176,225 | $262,252 |
| End Cash | $275,138 | $275,138 | $293,856 | $176,225 |
| Free Cash Flow | -$231,166 | -$231,166 | -$79,537 | -$91,212 |